Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 2
2006 4
2007 4
2008 3
2009 2
2010 2
2011 3
2012 4
2013 5
2014 2
2015 1
2016 6
2017 4
2018 5
2019 4
2020 5
2021 5
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Proteinase 3 phosphonic inhibitors.
Grzywa R, Lesner A, Korkmaz B, Sieńczyk M. Grzywa R, et al. Among authors: korkmaz b. Biochimie. 2019 Nov;166:142-149. doi: 10.1016/j.biochi.2019.03.005. Epub 2019 Mar 13. Biochimie. 2019. PMID: 30876969 Review.
Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D, Zhang J, Korkmaz B, Chalmers JD, Basso J, Lasala D, Fernandez C, Teper A, Mange KC, Perkins WR, Sullivan EJ. Cipolla D, et al. Among authors: korkmaz b. Respir Res. 2023 May 17;24(1):133. doi: 10.1186/s12931-023-02444-z. Respir Res. 2023. PMID: 37198686 Free PMC article. Clinical Trial.
Gut Serpinome: Emerging Evidence in IBD.
Mkaouar H, Mariaule V, Rhimi S, Hernandez J, Kriaa A, Jablaoui A, Akermi N, Maguin E, Lesner A, Korkmaz B, Rhimi M. Mkaouar H, et al. Among authors: korkmaz b. Int J Mol Sci. 2021 Jun 4;22(11):6088. doi: 10.3390/ijms22116088. Int J Mol Sci. 2021. PMID: 34200095 Free PMC article. Review.
Cathepsin C inhibition as a potential treatment strategy in cancer.
Korkmaz B, Lamort AS, Domain R, Beauvillain C, Gieldon A, Yildirim AÖ, Stathopoulos GT, Rhimi M, Jenne DE, Kettritz R. Korkmaz B, et al. Biochem Pharmacol. 2021 Dec;194:114803. doi: 10.1016/j.bcp.2021.114803. Epub 2021 Oct 20. Biochem Pharmacol. 2021. PMID: 34678221 Review.
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Kriaa A, Mariaule V, Jablaoui A, Rhimi S, Mkaouar H, Hernandez J, Korkmaz B, Lesner A, Maguin E, Aghdassi A, Rhimi M. Kriaa A, et al. Among authors: korkmaz b. Cells. 2022 Mar 5;11(5):901. doi: 10.3390/cells11050901. Cells. 2022. PMID: 35269523 Free PMC article. Review.
Targeting Cathepsin C in PR3-ANCA Vasculitis.
Jerke U, Eulenberg-Gustavus C, Rousselle A, Nicklin P, Kreideweiss S, Grundl MA, Eickholz P, Nickles K, Schreiber A, Korkmaz B, Kettritz R. Jerke U, et al. Among authors: korkmaz b. J Am Soc Nephrol. 2022 May;33(5):936-947. doi: 10.1681/ASN.2021081112. Epub 2022 Mar 15. J Am Soc Nephrol. 2022. PMID: 35292437 Free PMC article.
Selective inhibitors of human neutrophil proteinase 3.
Korkmaz B, Kellenberger C, Viaud-Massuard MC, Gauthier F. Korkmaz B, et al. Curr Pharm Des. 2013;19(6):966-76. doi: 10.2174/1381612811319060002. Curr Pharm Des. 2013. PMID: 23016687 Review.
Therapeutic targeting of cathepsin C: from pathophysiology to treatment.
Korkmaz B, Caughey GH, Chapple I, Gauthier F, Hirschfeld J, Jenne DE, Kettritz R, Lalmanach G, Lamort AS, Lauritzen C, Łȩgowska M, Lesner A, Marchand-Adam S, McKaig SJ, Moss C, Pedersen J, Roberts H, Schreiber A, Seren S, Thakker NS. Korkmaz B, et al. Pharmacol Ther. 2018 Oct;190:202-236. doi: 10.1016/j.pharmthera.2018.05.011. Epub 2018 May 26. Pharmacol Ther. 2018. PMID: 29842917 Review.
66 results